RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
Back
Abstract Number
WCN23-1043
Categories
Late Breaking Clinical Trials
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
Co-authors
Yu, J.(1)*;Chen, W.(1);Fan, L.(2);Chen, M.(3);Wan, J.(4);Wan, Q.(5);Kong, Y.(6);Xu, D.(7);Liang, X.(2);Xueqing, Y.(2);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)The First Affiliated Hospital Of Sun Yat-Sen University, Department Of Nephrology, Guangzhou, China;(2)Guangdong Provincial People'S Hospital, Department Of Nephrology, Guangzhou, China;(3)General Hospital Of Ningxia Medical University, Department Of Nephrology, Yinchuan, China;(4)The First Affiliated Hospital Of Fujian Medical University, Department Of Nephrology, Fuzhou, China;(5)Shenzhen Second People'S Hospital, Department Of Nephrology, Shenzhen, China;(6)The First People'S Hospital Of Foshan, Department Of Nephrology, Foshan, China;(7)Shandong Provincial Qianfo Hospital, Department Of Nephrology, Jinan, China;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/f387f5b222f1407a394571e882d37f10.pdf
Audio File
if any